Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Changes of Shareholders' Equity

v3.22.2.2
Condensed Statements of Changes of Shareholders' Equity - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balances, Beginning at Dec. 31, 2020 $ 830 $ 57,905,164 $ (27,965,105) $ 29,940,889
Balances, Beginning (in shares) at Dec. 31, 2020 8,305,075      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation expense   24,825   24,825
Exercise of warrants $ 3 197,559   197,562
Exercise of warrants (in shares) 25,315      
Net loss     (3,056,033) (3,056,033)
Balances, Ending at Mar. 31, 2021 $ 833 58,127,548 (31,021,138) 27,107,243
Balances, Ending (in shares) at Mar. 31, 2021 8,330,390      
Balances, Beginning at Dec. 31, 2020 $ 830 57,905,164 (27,965,105) 29,940,889
Balances, Beginning (in shares) at Dec. 31, 2020 8,305,075      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss       (11,448,977)
Balances, Ending at Sep. 30, 2021 $ 833 58,293,698 (39,414,082) 18,880,449
Balances, Ending (in shares) at Sep. 30, 2021 8,330,390      
Balances, Beginning at Mar. 31, 2021 $ 833 58,127,548 (31,021,138) 27,107,243
Balances, Beginning (in shares) at Mar. 31, 2021 8,330,390      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation expense   34,244   34,244
Net loss     (4,282,962) (4,282,962)
Balances, Ending at Jun. 30, 2021 $ 833 58,161,792 (35,304,100) 22,858,525
Balances, Ending (in shares) at Jun. 30, 2021 8,330,390      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation expense   131,906   131,906
Net loss     (4,109,982) (4,109,982)
Balances, Ending at Sep. 30, 2021 $ 833 58,293,698 (39,414,082) 18,880,449
Balances, Ending (in shares) at Sep. 30, 2021 8,330,390      
Balances, Beginning at Dec. 31, 2021 $ 833 58,425,604 (43,925,373) 14,501,064
Balances, Beginning (in shares) at Dec. 31, 2021 8,330,390      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation expense   131,906   131,906
Net loss     (3,960,308) (3,960,308)
Balances, Ending at Mar. 31, 2022 $ 833 58,557,510 (47,885,681) 10,672,662
Balances, Ending (in shares) at Mar. 31, 2022 8,330,390      
Balances, Beginning at Dec. 31, 2021 $ 833 58,425,604 (43,925,373) 14,501,064
Balances, Beginning (in shares) at Dec. 31, 2021 8,330,390      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss       (10,203,278)
Balances, Ending at Sep. 30, 2022 $ 1,833 63,351,653 (54,128,651) 9,224,835
Balances, Ending (in shares) at Sep. 30, 2022 18,330,390      
Balances, Beginning at Mar. 31, 2022 $ 833 58,557,510 (47,885,681) 10,672,662
Balances, Beginning (in shares) at Mar. 31, 2022 8,330,390      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation expense   136,957   136,957
Net loss     (3,667,255) (3,667,255)
Balances, Ending at Jun. 30, 2022 $ 833 58,694,467 (51,552,936) 7,142,364
Balances, Ending (in shares) at Jun. 30, 2022 8,330,390      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common shares, net of costs $ 1,000 4,492,920   4,493,920
Issuance of common shares, net of costs (shares) 10,000,000      
Share-based compensation expense   164,266   164,266
Net loss     (2,575,715) (2,575,715)
Balances, Ending at Sep. 30, 2022 $ 1,833 $ 63,351,653 $ (54,128,651) $ 9,224,835
Balances, Ending (in shares) at Sep. 30, 2022 18,330,390